lung cancer

2017 ASCO Annual Meeting. #ASCO17
June 5, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: Advances in Immunotherapy for Multiple Myeloma and Mesothelioma, and Targeted Therapies for Non-Small Cell Lung Cancer and HER2-Positive Breast Cancer

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 4, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: Symptom Reporting Extends Lives, Shorter Chemotherapy for Some Colon Cancer Patients, and Targeted Therapy in BRCA-Related Breast Cancer

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 3, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.

Read More >>
April 6, 2017
Nathan A. Pennell, MD, PhD

Helping People With Lung Cancer by Working Together

English
Nathan.Pennell

The Multidisciplinary Thoracic Cancers Symposium brings oncology professionals together to discuss ways to best treat people with lung cancer and other thoracic cancers. Dr. Nathan Pennell describes some of the research presented on targeted therapy, radiation therapy, and health disparities.

Read More >>
November 8, 2016
Jyoti Patel, MD

9 Things to Know About Immunotherapy and Lung Cancer

English
jyoti.patel

Recent FDA approvals for immunotherapy drugs for treating lung cancer are exciting, but there still are many things we need to learn about this new field of cancer treatment. Cancer.Net Associate Editor Jyoti Patel, MD, answers some of the questions that surround lung cancer and immunotherapy, during Lung Cancer Awareness Month.

Read More >>

Pages

Subscribe to RSS - lung cancer